Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $928,625 - $1.23 Million
-9,500 Reduced 76.0%
3,000 $381,000
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $818,688 - $1.08 Million
9,600 Added 331.03%
12,500 $1.35 Million
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $171,709 - $269,410
2,900 New
2,900 $265,000
Q3 2023

Nov 14, 2023

BUY
$43.4 - $62.52 $117,180 - $168,804
2,700 New
2,700 $119,000
Q1 2023

May 15, 2023

SELL
$36.57 - $58.29 $18,285 - $29,145
-500 Reduced 13.16%
3,300 $183,000
Q4 2022

Feb 14, 2023

BUY
$34.17 - $47.91 $58,089 - $81,447
1,700 Added 80.95%
3,800 $152,000
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $77,553 - $119,028
2,100 New
2,100 $92,000
Q1 2022

May 16, 2022

SELL
$30.32 - $91.33 $982,368 - $2.96 Million
-32,400 Reduced 78.83%
8,700 $354,000
Q4 2021

Feb 14, 2022

BUY
$86.26 - $119.0 $3.51 Million - $4.84 Million
40,700 Added 10175.0%
41,100 $3.84 Million
Q3 2021

Nov 15, 2021

SELL
$100.17 - $126.36 $350,595 - $442,260
-3,500 Reduced 89.74%
400 $45,000
Q2 2021

Aug 16, 2021

SELL
$86.05 - $119.72 $817,475 - $1.14 Million
-9,500 Reduced 70.9%
3,900 $443,000
Q1 2021

May 17, 2021

SELL
$91.47 - $124.36 $1.51 Million - $2.05 Million
-16,500 Reduced 55.18%
13,400 $1.36 Million
Q4 2020

Feb 16, 2021

BUY
$66.66 - $111.74 $1.43 Million - $2.4 Million
21,500 Added 255.95%
29,900 $2.98 Million
Q3 2020

Nov 16, 2020

SELL
$45.89 - $72.67 $917,800 - $1.45 Million
-20,000 Reduced 70.42%
8,400 $607,000
Q2 2020

Aug 14, 2020

BUY
$26.36 - $49.86 $748,624 - $1.42 Million
28,400 New
28,400 $1.42 Million
Q1 2020

May 15, 2020

SELL
$17.27 - $40.17 $164,065 - $381,615
-9,500 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$32.1 - $40.4 $304,950 - $383,800
9,500 New
9,500 $320,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.